![Seth Orlow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth Orlow
Directeur/Bestuurslid bij
ALMIRALL, S.A.
Profiel
Seth J.
Orlow was the founder of Ivrea Pharmaceuticals, Inc., founded in 2005, where the title held was Director.
Dr. Orlow is also the founder of Anaderm Research Corp...
Dr. Orlow currently serves as Independent Director at Almirall SA since 2016.
Dr. Orlow is Director at R2 Dermatology, Inc., Director at R2 Technologies, Inc. (California), and Professor at New York University.
Former positions include Director at Coapt Systems, Inc., Director at Protez Pharmaceuticals, Inc., Director at Transave, Inc., Managing Director at Easton Capital Investment Group, Trustee at Dermatology Foundation, Partner at Easton Capital Partners LP, and Professor at Nyu Grossman School of Medicine.
Education includes a doctorate from Albert Einstein College of Medicine, Inc. and an undergraduate degree from Harvard College.
Actieve functies van Seth Orlow
| Bedrijven | Functie | Begin |
|---|---|---|
| ALMIRALL, S.A. | Directeur/Bestuurslid | 01-01-2016 |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
R2 Dermatology, Inc.
 R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company specializing in cryoaesthetics medical devices, focusing on advanced cryotherapy-based skin treatments. The company is based in New York, NY. R2 Dermatology develops proprietary cryomodulation technology that uses precision contact cooling to reduce skin inflammation, redness, and signs of premature aging. Its flagship Glacial skin platform includes FDA-cleared and health-licensed devices such as Glacial Rx, a cryosurgical instrument for dermatologic procedures, and Glacial Fx, a compact wellness device. These devices deliver customizable treatments that promote skin regeneration, improve brightness, texture, tone, and hydration, and can be combined with other aesthetic procedures. The Glacial treatment modalities include Gloss Rx, Glide Rx, Glide Rx combinations, and Freeze for benign lesion removal. R2 Dermatology offers the Glacial Peak program, a tiered premium membership for dermatology practices, providing consumables, shipping, warranty coverage, marketing support, provider listings, discounts, certification, and ongoing education. The company maintains a patent portfolio protecting its Glacial line and technologies and targets healthcare providers and patients, offering educational resources and training. The CEO of the company is Gordon E. Nye. | Directeur/Bestuurslid | - |
R2 Technologies, Inc. (California)
 R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots | Directeur/Bestuurslid | - |
Eerdere bekende functies van Seth Orlow
| Bedrijven | Functie | Einde |
|---|---|---|
Nyu Grossman School of Medicine
 Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Easton Capital Partners LP
 Easton Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Directeur/Bestuurslid | - |
Dermatology Foundation | Directeur/Bestuurslid | - |
Anaderm Research Corp. | Oprichter | - |
Opleiding van Seth Orlow
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
76
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Easton Capital Partners LP
Easton Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Coapt Systems, Inc.
 Coapt Systems, Inc. BiotechnologyHealth Technology Manufactures and markets bioabsorbable implants | Health Technology |
Ivrea Pharmaceuticals, Inc.
 Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions | Health Technology |
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Protez Pharmaceuticals, Inc.
 Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
Easton Capital Investment Group
 Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Finance |
Dermatology Foundation | |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anaderm Research Corp. | |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R2 Dermatology, Inc.
R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company specializing in cryoaesthetics medical devices, focusing on advanced cryotherapy-based skin treatments. The company is based in New York, NY. R2 Dermatology develops proprietary cryomodulation technology that uses precision contact cooling to reduce skin inflammation, redness, and signs of premature aging. Its flagship Glacial skin platform includes FDA-cleared and health-licensed devices such as Glacial Rx, a cryosurgical instrument for dermatologic procedures, and Glacial Fx, a compact wellness device. These devices deliver customizable treatments that promote skin regeneration, improve brightness, texture, tone, and hydration, and can be combined with other aesthetic procedures. The Glacial treatment modalities include Gloss Rx, Glide Rx, Glide Rx combinations, and Freeze for benign lesion removal. R2 Dermatology offers the Glacial Peak program, a tiered premium membership for dermatology practices, providing consumables, shipping, warranty coverage, marketing support, provider listings, discounts, certification, and ongoing education. The company maintains a patent portfolio protecting its Glacial line and technologies and targets healthcare providers and patients, offering educational resources and training. The CEO of the company is Gordon E. Nye. | |
R2 Technologies, Inc. (California)
R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots | Health Technology |
Nyu Grossman School of Medicine
Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
